Pooled Exposure-Response (ER) and Quantitative Benefit/Risk (B/R) Analyses Support the Approved Copanlisib Intermittent Dosing RegimenPeter N. Morcos,Jonathan Moss,Charles Phelps,Florian J. R. Hiemeyer,Barrett H. Childs,Martin Dreyling,Pier Luigi Zinzani,Dirk GarmannBLOOD(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要